Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371:836–45.
Article CAS PubMed Google Scholar
de Jonge PJ, van Blankenstein M, Grady WM, et al. Barrett’s oesophagus: epidemiology, cancer risk and implications for management. Gut. 2014;63:191–202.
Clermont M, Falk GW. Clinical guidelines update on the diagnosis and management of Barrett’s esophagus. Dig Dis Sci. 2018;63:2122–8.
Koizumi S, Motoyama S, Iijima K. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan. J Gastroenterol. 2018;53:827–33.
Matsuno K, Ishihara R, Ohmori M, et al. Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. J Gastroenterol. 2019;54:784–91.
Article CAS PubMed Google Scholar
Nishi T, Makuuchi H, Ozawa S, et al. The present status and future of Barrett’s ssophageal adenocarcinoma in Japan. Digestion. 2019;99:185–90.
Kusano C, Singh R, Lee YY, et al. Global variations in diagnostic guidelines for Barrett’s esophagus. Dig Endosc. 2022;34:1320–8.
Iwakiri K, Fujiwara Y, Manabe N, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021. J Gastroenterol. 2022;57:267–85.
Article CAS PubMed PubMed Central Google Scholar
Kitagawa Y, Ishihara R, Ishikawa H, et al. Esophageal cancer practice guidelines 2022 edited by the Japan Esophageal Society: part 2. Esophagus. 2023;20:373–89.
Article PubMed PubMed Central Google Scholar
Matsuhashi N, Sakai E, Ohata K, et al. Surveillance of patients with long-segment Barrett’s esophagus: a multicenter prospective cohort study in Japan. J Gastroenterol Hepatol. 2017;32:409–14.
Sugano K, Spechler SJ, El-Omar EM, et al. Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction. Gut. 2022;71:1488–514.
Adachi K, Ishimura N, Kishi K, et al. Prevalence of Barrett’s epithelium shown by endoscopic observations with linked color imaging in subjects with different H. pylori infection statuses. Intern Med. 2021;60:667–74.
Eusebi LH, Cirota GG, Zagari RM, et al. Global prevalence of Barrett’s oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis. Gut. 2021;70:456–63.
Article CAS PubMed Google Scholar
Lin Y, Wang HL, Fang K, et al. International trends in esophageal cancer incidence rates by histological subtype (1990–2012) and prediction of the rates to 2030. Esophagus. 2022;19:560–8.
Curtius K, Rubenstein JH, Chak A, et al. Computational modelling suggests that Barrett’s oesophagus may be the precursor of all oesophageal adenocarcinomas. Gut. 2020;70:1435–40.
Fukuda S, Watanabe K, Yoshida T, et al. Low risk of esophageal adenocarcinoma among patients with ultrashort-segment Barrett’s esophagus in Japan. Dig Endosc. 2022;34:757–65.
Hamashima C, Fukao A. Quality assurance manual of endoscopic screening for gastric cancer in Japanese communities. Jpn J Clin Oncol. 2016;46:1053–61.
Siewert JR, Stein HJ. Classification of carcinoma of the oesophagogastric junction. Br J Surg. 1998;85:1457–9.
Article CAS PubMed Google Scholar
Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.
Article CAS PubMed Google Scholar
Kimura K, Takemoto T. An endoscopic recognition of the atrophic border and its significance in chronic gastritis. Endoscopy. 1969;3:87–97.
Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology. 2006;131:1392–9.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Article CAS PubMed Google Scholar
Iijima K, Watanabe K, Shimodaira Y, et al. A final report on the real impact of the COVID-19 pandemic on the diagnosis of gastrointestinal cancer in Akita prefecture, Japan in 2022. Tohoku J Exp Med. 2024. https://doi.org/10.1620/tjem.2024.J025.
Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784–9.
Article CAS PubMed Google Scholar
Kaji K, Hashiba A, Uotani C, et al. Grading of atrophic gastritis is useful for risk stratification in endoscopic screening for gastric cancer. Am J Gastroenterol. 2019;114:71–9.
Ishihara R, Oyama T, Abe S, et al. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52:800–8.
Norita K, Koike T, Saito M, et al. Long-term endoscopic surveillance for Barrett’s esophagus in Japan: multicenter prospective cohort study. Dig Endosc. 2021;33:1085–92.
Lee YC, Cook MB, Bhatia S, et al. Interobserver reliability in the endoscopic diagnosis and grading of Barrett’s esophagus: an Asian multinational study. Endoscopy. 2010;42:699–704.
Article CAS PubMed PubMed Central Google Scholar
Ishimura N, Yuki M, Yuki T, et al. Inter-institutional variations regarding Barrett’s esophagus diagnosis. Esophagus. 2019;16:71–6.
Thota PN, Vennalaganti P, Vennelaganti S, et al. Low risk of high-grade dysplasia or esophageal adenocarcinoma among patients with Barrett’s esophagus less than 1 cm (irregular Z line) within 5 years of index endoscopy. Gastroenterology. 2017;152:987–92.
Okuyama A, Watabe M, Makoshi R, et al. Impact of the COVID-19 pandemic on the diagnosis of cancer in Japan: analysis of hospital-based cancer registries. Jpn J Clin Oncol. 2022;52:1215–24.
Comments (0)